The death rate from asthma is highest in old age and continues to rise, despite diagnostic and therapeutic advances.'3 Acute attacks of asthma in older people with chronic asthma may be very rapidly fatal4 and have been said to have a poorer prognosis than in the young.5 Of the many potential reasons for the higher mortality from asthma in old age, the possibility of impaired awareness of the severity of an acute asthmatic attack by the elderly patient, his physician, or both has been little investigated. Petheram et al 6 showed that during acute exacerbations of asthma elderly patients have less pronounced pulsus paradoxus and tachycardia than younger patients with similar airway obstruction and blood gas abnormalities. They argued that this might theoretically result in undertreatment of the elderly asthmatic patient during an acute attack. Treatment might also be inadequate if the severity of the attack were also underestimated by the patient. This may indeed be the case in the elderly. Elderly asthmatic patients tend to deteriorate for longer periods at home before admission,6 and when challenged with inhaled methacholine they do not report dyspnoea or wheeze to be troublesome despite a minimum fall in one second expiratory volume (FEV,) 
M j Connolly, J J Crowley, N B Charan, C P Nielson, R E Vestal Abstract Background Asthma death rates are rising, with the greatest rise and highest death rates in old age. A reduced cardiovascular response in the elderly may lead to the underestimation by physicians of the severity of acute asthma attacks. This would be compounded if elderly patients had reduced awareness of bronchoconstriction. Methods Methacholine provoked bronchoconstriction was compared in 34 elderly (17 asthmatic, 17 normal; age 60-83, mean 68 years) and 33 young subjects (16 asthmatic, 17 normal; 20-46, mean 30 years). None were smokers. All underwent inhaled methacholine challenge by the Newcastle dosimeter method, monitored by maximal expiratory flowvolume loops (MEFVL). The endpoints were a 35% fall in forced expiratory flow at 50% vital capacity or cumulative inhalation of 6-4 mg methacholine. The one second forced expiratory volume (FEVy) was derived from MEFVL. After challenge and before bronchodilatation subjects graded awareness of respiratory discomfort from 1 (no symptoms) to 4 (pronounced symptoms needing immediate treatment).
Results Despite a greater fall in FEV, in elderly asthmatic patients (mean (SE) 27'4% (2-2%)) than in young asthmatic patients (21-5% (1-7%)) elderly patients were less aware of bronchoconstriction (awareness scrS tn young patients (3-06 (011) The death rate from asthma is highest in old age and continues to rise, despite diagnostic and therapeutic advances.'3 Acute attacks of asthma in older people with chronic asthma may be very rapidly fatal4 and have been said to have a poorer prognosis than in the young.5 Of the many potential reasons for the higher mortality from asthma in old age, the possibility of impaired awareness of the severity of an acute asthmatic attack by the elderly patient, his physician, or both has been little investigated. Petheram et al 6 showed that during acute exacerbations of asthma elderly patients have less pronounced pulsus paradoxus and tachycardia than younger patients with similar airway obstruction and blood gas abnormalities. They argued that this might theoretically result in undertreatment of the elderly asthmatic patient during an acute attack. Treatment might also be inadequate if the severity of the attack were also underestimated by the patient. This may indeed be the case in the elderly. Elderly asthmatic patients tend to deteriorate for longer periods at home before admission, 6 (1) elderly asthmatic patients aged 60 years and over; (2) elderly normal individuals aged 60 years and over; (3) young asthmatic patients aged 18-50 years; (4) young normal individuals aged 18-50 years. Asthma was defined as a history of spontaneous wheezing with documented variability in FEVy of at least 15%. Normal subjects were defined as those with no present or past history of respiratory disease and with baseline FEVy within the normal range. Individuals were excluded if they had smoked any form of tobacco within 10 years or had a history oftotal cigarette consumption of 10 pack years or more. The following were also exclusion criteria: pregnancy; cognitive impairment; cardiac disorder; current treatment with ,B adrenergic antagonists or with oral ,B adrenergic agonists, calcium antagonists, or angiotensin converting enzyme inhibitors; past or present thyroid disorder; treatment with systemic corticosteroids in the previous six weeks; respiratory tract infection in the previous six weeks; baseline FEV, less than 60% of predicted or less than 1 litre. STUDY 
DESIGN
The study was part of a larger project (unpublished) examining the relation between bronchial responsiveness and mononuclear cell f, adrenoceptor parameters, for which all subjects underwent two methacholine challenges on separate, non-consecutive days within a seven day period. The selection criteria for this larger project were identical to those described above and all subjects participated in both studies. All tests were performed between 10 am and 4 pm, and for each subject tests were performed at the same time of day (+ 2 hours). Before being included all potential subjects were screened by full history and examination, and a serum pregnancy test was performed where appropriate. All subjects were asked to abstain from drinks containing caffeine and from all oral medications for 24 hours before each challenge (48 hours for "sustained release" preparations), and from all inhaled medications for 12 hours before each challenge.
Methacholine challenge testing was performed by a dosimeter technique using a computer controlled Newcastle dosimeter"l and Acorn System 22 Turbo nebulisers (MedicAid Ltd, Pagham, Sussex), the output of which was controlled at 10 p1 (standard deviation less than 2-5%) per inhalation. Bronchoconstriction was monitored by maximal expiratory flow-volume loops on a Gould 5000 IV pulmonary function unit with a System 21 pulmonary work station (Gould, Dayton, Ohio, USA). The reason for this exercise was not discussed with the subjects, nor were they aware of the percentage fall in FEV, or FEF50. The sensation of bronchoconstriction was described to normal subjects (before methacholine challenge) as "chest tightness, discomfort, or breathlessness." All subjects were instructed to rank their overall respiratory discomfort (that is, the scale was deliberately subjective and non-specific) but were asked to ignore nonrespiratory side effects ofmethacholine (such as salivation and flushing).
All subjects gave written informed consent to participation in the protocol, which was approved by human subjects committee of the University of Washington and the research and development committee of the Boise Veterans' Affairs Medical Center.
DATA ANALYSIS
Awareness scores for different groups of subjects were compared by X 2 analysis. Unpaired t tests were used to compare the degree of bronchoconstriction produced in the groups of subjects. To assess whether awareness of bronchoconstriction was related to the total dose ofmethacholine administered in each age group, total cumulative doses of methacholine were ranked in three previously defined categories, ' (16-3 (1-3)) and young normal subjects (1-7)). The mean awareness score in elderly normal subjects was lower (1-53 (0-17)) than in young normal subjects (2-76 (0 22); p = 0 004). Asthmatic subjects The mean percentage fall in FEV1 for asthmatic patients was 246 (1) (2) (3) (4) (5) . Elderly asthmatic patients had somewhat greater percentage falls (mean 27-4 (2 2)) than young patients (21X5 (1-7) ; p < 0 001). Despite this, elderly asthmatic patients had much lower awareness scores (2-00 (0-15)) than young patients (3-06 (0X11); p < 0X001).
There was no relation between awareness scores (day 1) and the total cumulative dose of methacholine administered either overall or in the subgroups of elderly or young subjects. There was no relation between awareness scores and duration of asthma in either asthmatic patients overall or in elderly or young asthmatic patients.
Rank correlation showed good agreement between awareness scores on days 1 and 2, whether in all subjects (rho = 0-82, p < 0-001), normal subjects (rho = 0-89, p < 0-001), or asthmatic patients (rho = 0-64, p < 0-001) or in the four subgroups (p < 0-001, all cases).
Discussion
This study has shown that, despite equivalent or greater percentage falls in FEVy in the elderly, older subjects were less aware of acute bronchoconstriction than the young. This difference was independent of the presence of asthma. There was no relationship, either overall or within age groups, between the dose of methacholine needed to provoke bronchoconstriction to a defined endpoint (an index of the presence and severity of asthma9 10 1416) and the degree of awareness. Furthermore, awareness was unrelated to duration ofasthma, either in asthmatic patients overall or in the subgroups of elderly or young asthmatic subjects.
The difference in awareness between the elderly and the young was maintained on day 2, and thus is unlikely to be due to "overreporting" of discomfort due to anxiety by young non-asthmatic subjects who had no prior experience of bronchoconstriction. Moreover, the difference in awareness between young and old was also seen in asthmatic patients, who are familiar with bronchoconstriction whatever their age. Furthermore, there is no evidence that the old would complain less than the young about distressing symptoms if sensory input were intact. Indeed, the opposite may be true.17
The awareness score we used was chosen to be as simple as possible for elderly patients and deliberately to reflect a subjective and nonspecific awareness of respiratory symptoms associated with bronchoconstriction rather than an attempted objective assessment by the physician. It was shown to be reproducible both overall and in all groups of subjects.
The possible causes of reduced awareness of bronchoconstriction in the elderly are many and varied. Sensory input from the lungs is transmitted by three types of receptor-the stretch receptor, the irritant receptor, and the J receptor.8 19 J receptors primarily react to increased pulmonary capillary pressure, '9 and are thus unlikely to play a part in awareness of bronchoconstriction provoked by irritants. Stretch receptors may produce termination of deep inspiration. Their stimulation also produces tachycardia and they are responsible for the Hering-Breuer reflex.'9 As both the tachycardic response to bronchoconstriction and the Hering-Breuer reflex diminish with age,6 20 conceivably impaired awareness of bronchoconstriction may result from a reduced number or activity of stretch receptors in old age. Their blockade, however, increases rather than decreases dyspnoea during the breathing of gases enriched with carbon dioxide.2' Irritant receptors are one route by which methacholine produces bronchoconstriction.'9 As methacholine responsiveness is not impaired in old age-indeed, it may be enhanced22-reduced activity of irritant receptors seems unlikely to be important in impaired awareness of bronchoconstriction, even though they help to produce unpleasant respiratory sensations.'9"2 This is consistent with our finding of no association between bronchial responsiveness and awareness.
Reduced sensitivity of chemoreceptors to hypoxia in the elderly24 may be relevant. We did not estimate blood gas tensions, but bronchial challenge may produce arterial desaturation. 25 Elderly people have impaired perception of externally applied resistive and elastic respiratory loads,26 27 perhaps because of impaired perception of joint movement or tactile sensation,2830 and such abnormalities may be also relevant to the present study, as may age related abnormalities in central processing. [31] [32] [33] Further research is needed to establish the mechanism or mechanisms of reduced subjective awareness of bronchoconstriction in old age. Whatever the mechanism, however, this observation has important implications. Mortality from asthma not only is highest in the elderly but is rising most in this age group. '3 Possibly the disproportionate rise in deaths from asthma in the elderly results partially from a shift in diagnostic labelling from chronic obstructive airways disease to asthma,34 and whether excessive asthma mortality in the aged result from primary uncomplicated asthma or from other age associated conditions is not clear. There is evidence, however, that chronicity of asthma is a risk factor,5 and the excessive asthma mortality in the aged is likely to be multifactorial. Impaired awareness of bronchoconstriction may contribute by leading to delayed self referral during acute asthmatic attacks. The problem merits wider recognition and should be a further stimulus to precise diagnosis, improved education of patients, and effective treatment and monitoring of asthma in old age.
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